A therapeutic approach to nasopharyngeal carcinomas by DNAzymes targeting EBV LMP-1 gene

Molecules

Volumn 15, Issue 9, 2010, Pages 6127-6139

  Yang, Lifang ^a,b   Lu, Zhongxin ^a   Ma, Xiaoqian ^a   Cao, Ya ^a   Sun, Lun Quan ^b,c  

^a The First People s Hospital of Changde City)   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

^c UNIVERSITY OF TECHNOLOGY SYDNEY   (Australia)

Author keywords

DNAzyme; LMP1; NPC; Targeted therapy

Indexed keywords

EID: 77957325051     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules15096127     Document Type: Review

References (42)

1. Yu, M. C.; Yuan, J. M. Epidemiology of nasopharyngeal carcinoma. Semin. Cancer Biol. 2002. 12, 421-429.
2. Herrmann, K.; Niedobitek, G. Epstein-Barr virus-associated carcinomas: Facts and fiction. J. Pathol. 2003, 199; 140-145.
3. Chou, J.; Lin, Y. C.; Kim, J.; You, L.; Xu, Z.; He, B.; Jablons, D. M. Nasopharyngeal carcinoma-review of the molecular mechanisms of tumorigenesis. Head Neck 2008, 30, 946-963.
4. Tsao, S. W.; Tramoutanis, G.; Dawson, C. W.; Lo, A. K.; Huang, D. P. The significance of LMP1 expression in nasopharyngeal carcinoma. Semin. Cancer Biol. 2002, 12, 473-487.
5. Morris, M. A.; Dawson, C. W.; Young, L. S. Role of the Epstein-Barr virus-encoded latent membrane protein-1, LMP1, in the pathogenesis of nasopharyngeal carcinoma. Future Oncol. 2009, 5, 811-825.
6. Eliopoulos, A. G.; Young, L. S. LMP1 structure and signal transduction. Semin. Cancer. Biol. 2001, 11, 435-444.
7. Zheng, H.; Li, L. L.; Hu, D. S.; Deng, X. Y.; Cao, Y. Role of Epstein-Barr virus encoded latent membrane protein 1 in the carcinogenesis of nasopharyngeal carcinoma. Cell Mol. Immunol. 2007, 4, 185-196.
8. Hatzivassiliou, E.; Mosialos, G. Cellular signaling pathways engaged by the Epstein-Barr virus transforming protein LMP1. Front Biosci. 2002, 7, d319-d329.
9. Li, H. P.; Chang, Y. S. Epstein-Barr virus latent membrane protein 1: Structure and functions. J. Biomed. Sci. 2003, 10, 490-504.
10. Horikawa, T.; Yang, J.; Kondo, S.; Yoshizaki, T.; Joab, I.; Furukawa, M.; Pagano, J. S. Twist and epithelial-mesenchymal transition are induced by the EBV oncoprotein latent membrane protein 1 and are associated with metastatic nasopharyngeal carcinoma. Cancer Res. 2007, 67, 1970-1978.
11. Dawson, C. W.; Laverick, L.; Morris, M. A.; Tramoutanis, G.; Young, L. S. Epstein-Barr virusencoded LMP-1 regulates epithelial cell motility and invasion via the Erk-MAPK pathway. J. Virol. 2008, 82, 3654-3664.
12. Breaker, R. R.; Joyce, G. F. A DNA enzyme that cleaves RNA. Chem. Biol. 1994, 1, 223-229.
13. Breaker, R. R.; Joyce, G. F. A DNA enzyme with Mg (2+)-dependent RNA phosphoesterase activity. Chem. Biol. 1995, 2, 655-660.
14. Santoro, S. W.; Joyce, G. F. A general purpose RNA-cleaving DNA enzyme. Proc. Natl. Acad. Sci. USA 1997, 94, 4262-4266.
15. Santoro, S. W.; Joyce, G. F. Mechanism and utility of an RNA-cleaving DNA enzyme. Biochemistry 1998, 37, 13330-13342.
16. Breaker, R. R. DNA enzymes. Nat. Biotechnol. 1997, 15, 427-431.
17. Li, Y.; Breaker, R. R. Deoxyribozymes: New players in the ancient game of biocatalysis. Curr. Opin. Struct. Biol. 1999, 9, 315-323.
18. Dass, C. R.; Choong, P. F.; Khachigian, L. M. DNAzyme technology and cancer therapy: Cleave and let die. Mol. Cancer Ther. 2008, 7, 243-251.
19. Willner, I.; Shlyahovsky, B.; Zayats, M.; Willner, B. DNAzymes for sensing, nanobiotechnology and logic gate applications. Chem. Soc. Rev. 2008, 37, 1153-1165.
20. Fahmy, R. G.; Dass, C. R.; Sun, L. Q.; Chesterman, C. N.; Khachigian, L. M. Transcription factor Egr-1 supports FGF-dependent angiogenesis during neovascularization and tumor growth. Nat. Med. 2003, 9, 1026-1032.
21. Yang, L.; Xiao, L.; Ma, X.; Tang, M.; Weng, X.; Chen, X.; Sun, L.; Cao, Y. Effect of DNAzymes targeting akt1 on cell proliferation and apoptosis in nasopharyngeal carcinoma. Cancer Biol. Ther. 2009, 8, 366-371.
22. Bhindi, R.; Fahmy, R. G.; Lowe, H. C.; Chesterman, C. N.; Dass, C. R.; Cairns, M. J.; Saravolac, E. G.; Sun, L. Q.; Khachigian, L. M. Brothers in arms: DNA enzymes, short interfering RNA, and the emerging wave of small-molecule nucleic acid-based gene-silencing strategies. Am. J. Pathol. 2007, 171, 1079-1088.
23. Fielding, C. A.; Sandvej, K.; Mehl, A.; Brennan, P.; Jones, M.; Rowe, M. Epstein-Barr virus lmp-1 natural sequence variants differ in their potential to activate cellular signaling pathways. J. Virol. 2001, 75, 9129-9141.
24. Cairns, M. J.; Hopkins, T. M.; Witherington, C.; Wang, L.; Sun, L. Q. Target site selection for an RNA-cleaving catalytic DNA. Nat. Biotechnol. 1999, 17, 480-486.
25. Cairns, M. J.; King, A.; Sun, L. Q. Optimisation of the 10-23 DNAzyme-substrate pairing interactions enhanced RNA cleavage activity at purine-cytosine target sites. Nucl. Acids Res. 2003, 31, 2883-2889.
26. Nunamaker, E. A.; Zhang, H. Y.; Shirasawa, Y.; Benoit, J. N.; Dean, D. A. Electroporationmediated delivery of catalytic oligodeoxynucleotides for manipulation of vascular gene expression. Am. J. Physiol. Heart Circ. Physiol. 2003, 285, H2240-H2247.
27. Lu, Z. X.; Ye, M.; Yan, G. R.; Li, Q.; Tang, M.; Lee, L. M.; Sun, L. Q.; Cao, Y. Effect of EBV LMP11 targeted DNAzymes on cell proliferation and apoptosis. Cancer Gene Ther. 2005, 12, 647-654.
28. Dass, C. R.; Saravolac, E. G.; Li, Y.; Sun, L. Q. Cellular uptake, distribution, and stability of 10-23 deoxyribozymes. Antisense Nucleic Acid Drug Dev. 2002, 12, 289-299.
29. Benimetskaya, L.; Takle, G. B.; Vilenchik, M.; Lebedeva, I.; Miller, P.; Stein, C. A. Cationic porphyrins: Novel delivery vehicles for antisense oligodeoxynucleotides. Nucl. Acids Res. 1998, 26, 5310-5317.
30. Lu, Z. X.; Ma, X. Q.; Yang, L. F.; Wang, Z. L.; Zeng, L.; Li, Z. J.; Li, X. N.; Tang, M.; Yi, W.; Gong, J. P.; Sun, L. Q.; Cao, Y. DNAzymes targeted to EBV-encoded latent membrane protein-1 induce apoptosis and enhance radiosensitivity in nasopharyngeal carcinoma. Cancer Lett. 2008, 265, 226-238.
31. Yoshizaki, T.; Sato, H.; Furukawa, M.; Pagano, J. S. The expression of matrix metalloproteinase 9 is enhanced by Epstein-Barr virus latent membrane protein 1. Proc. Natl. Acad Sci. USA 1998, 95, 3621-3626.
32. Rubin, C. I.; Atweh, G. F. The role of stathmin in the regulation of the cell cycle. J. Cell Biochem. 2004, 93, 242-250.
33. Mistry, S. J.; Atweh, G. F. Role of stathmin in the regulation of the mitotic spindle: Potential applications in cancer therapy. Mt. Sinai J. Med. 2002, 69, 299-304.
34. Lin, X.; Liu, S.; Luo, X.; Ma, X.; Guo, L.; Li, L.; Li, Z.; Tao, Y.; Cao, Y. EBV-encoded LMP1 regulates op18/stathmin signaling pathway by cdc2 mediation in nasopharyngeal carcinoma cells. Int. J. Cancer 2009, 124, 1020-1027.
35. Korotayev, K.; Chaussepied, M.; Ginsberg, D. Erk activation is regulated by E2F1 and is essential for E2F1-induced s phase entry. Cell. Signal. 2008, 20, 1221-1226.
36. Ding, L.; Li, L.; Yang, J.; Zhou, S.; Li, W.; Tang, M.; Shi, Y.; Yi, W.; Cao, Y. Latent membrane protein 1 encoded by Epstein-Barr virus induces telomerase activity via p16ink4a/rb/e2f1 and jnk signaling pathways. J. Med. Virol. 2007, 79, 1153-1163.
37. Fan, M.; Ahmed, K. M.; Coleman, M. C.; Spitz, D. R.; Li, J. J. Nuclear factor-kappaB and manganese superoxide dismutase mediate adaptive radioresistance in low-dose irradiated mouse skin epithelial cells. Cancer Res. 2007. 67, 3220-3228.
38. Yin, L.; Liao, W.; Deng, X.; Tang, M.; Gu, H.; Li, X.; Yi, W.; Cao, Y. LMP1 activates NF-kappa B via degradation of I kappa B alpha in nasopharyngeal carcinoma cells. Chin. Med. J. (Engl.) 2001, 114, 718-722.
39. Sommer, S. S.; Jiang, Z.; Feng, J.; Buzin, C. H.; Zheng, J.; Longmate, J.; Jung, M.; Moulds, J.; Dritschilo, A. ATM missense mutations are frequent in patients with breast cancer. Cancer Genet. Cytogenet. 2003, 145, 115-120.
40. Pandita, T. K. A multifaceted role for ATM in genome maintenance. Expert Rev. Mol. Med. 2003, 5, 1-21.
41. Liu, Y. P.; Tan, Y. N.; Wang, Z. L.; Zeng, L.; Lu, Z. X.; Li, L. L.; Luo, W.; Tang, M.; Cao, Y. Phosphorylation and nuclear translocation of STAT3 regulated by the Epstein-Barr virus latent membrane protein 1 in nasopharyngeal carcinoma. Int. J. Mol. Med. 2008, 21, 153-162.
42. Lo, K. W.; To, K. F.; Huang, D. P. Focus on nasopharyngeal carcinoma. Cancer Cell 2004, 5, 423-428.